PI-LAB-2025-064

SS-31, Independent Lab Report

SS-31 10mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97% met the stated ≥98% claim. Content measured 100.7% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.0%

Label claimed ≥98%

Content accuracy
100.7%

10.07mg measured against 10mg claimed

Test recency
Older result

Published 16 months ago

Specimen PI-LAB-2025-064 Tested by Vantage Analytical Labs 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97% Within analytical tolerance
Identity (MS) SS-31 Confirmed Matches label
Content 10 mg 10.07 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Lot / batch
D1210-25
Purchased
Analysed
Published
Laboratory
Vantage Analytical Labs
Test type
Content verification

Original laboratory report: PI-LAB-2025-064-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, SS-31

SS-31 Lumen Research Supply
Purity 97.7% Verified